ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 42 filers reported holding ELOXX PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,859,000 | – | 167,474 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,930,092 | $1,363,000 | 0.55% |
| AMERICAN FINANCIAL GROUP INC | 1,480,000 | $1,045,000 | 0.29% |
| Vanguard Capital Wealth Advisors | 158,900 | $111,000 | 0.08% |
| Anson Funds Management LP | 553,652 | $391,000 | 0.04% |
| Nantahala Capital Management | 894,659 | $632,000 | 0.02% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,094,208 | $1,479,000 | 0.02% |
| Harel Insurance Investments & Financial Services Ltd. | 1,176,401 | $831,000 | 0.02% |
| Atom Investors LP | 113,151 | $80,000 | 0.01% |
| Virtu Financial LLC | 130,270 | $91,000 | 0.01% |
| Altshuler Shaham Ltd | 1,157,540 | $828,000 | 0.01% |